miR-146b 的靶点 IRAK1 降低人甲状腺乳头状癌细胞的侵袭性
本研究探讨 IRAK1 作为 miR-146b 潜在靶基因及其在甲状腺乳头状癌(PTC)中的作用:用全基因组芯片、计算分析和 3' UTR 报告基因试验鉴定 IRAK1 为 miR-146b 靶基因,并在 PTC 细胞系进行体外功能获得/缺失实验;50 例 PTC 及癌旁正常甲状腺标本用 qRT-PCR 检测表达。结果显示 IRAK1 是 miR-146b 直接靶点,具有抑制 PTC 多种侵袭性细胞活性的功能。
要点
- miR-146b 通过下调 IRAK1 表达促进 PTC 细胞迁移和增殖,恢复 IRAK1 表达可逆转该效应
- IRAK1 mRNA 在 PTC 临床组织中的表达显著低于癌旁正常甲状腺标本
- PTC 标本中 IRAK1 与 miR-146b 表达呈强负相关
核心结论
- IRAK1 是 miR-146b 的直接靶点,具有抑制多种 PTC 侵袭性细胞活性的功能。
- 联合现有治疗方案,靶向 miR-146b-IRAK1 轴可能为 PTC 管理提供潜在途径。
研究设计与样本
- 采用全基因组芯片、计算分析和 3' UTR 报告基因试验鉴定 IRAK1 为 miR-146b 靶基因。
- 在 PTC 癌细胞系进行体外功能获得/缺失实验,检测 IRAK1 对增殖、集落形成和伤口愈合的影响。
- 用 qRT-PCR 评估 50 例 PTC 及其癌旁正常甲状腺标本中 miR-146b 和 IRAK1 的表达水平。
主要发现
- 芯片表达谱显示 IRAK1 基因 mRNA 水平被 miR-146b 下调。
- 报告基因试验显示 IRAK1 mRNA 的 3' UTR 是 miR-146b 在 BCPAP 细胞中转录后抑制的分子靶点。
- miR-146b 通过下调 IRAK1 表达促进 PTC 细胞迁移和增殖,而恢复 IRAK1 表达可逆转该效应。
- IRAK1 mRNA 在 PTC 临床组织样本中的表达显著低于癌旁正常甲状腺标本,且在 PTC 标本中与 miR-146b 表达呈强负相关。
临床怎么用
- 原文结论提出靶向 miR-146b-IRAK1 轴联合现有治疗方案可能为 PTC 管理提供潜在途径。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: MicroRNA (miR)-146b is overexpressed in papillary thyroid carcinoma (PTC) and is associated with extrathyroidal invasion, advanced tumor stage, and poor prognosis. However, the underlying mechanism of miR-146b in relation to its oncogenic behavior in PTC and its putative targets remain unknown. OBJECTIVE: The purpose was to investigate IL-1 receptor-associated kinase 1 (IRAK1) as the potential miR-146b target gene and its involvement in PTC. DESIGN: We used genome-wide microarray, computational analysis, and 3' UTR reporter gene assays to identify IRAK1 as a miR-146b target gene. In vitro gain/loss-of-function experiments were further performed to determine the effects of IRAK1 on proliferation, colony formation, and wound-healing in PTC cancer cell lines. Expression levels of miR-146b and IRAK1 of 50 cases of PTC and its adjacent normal thyroid specimens were assessed via qRT-PCR. RESULTS: Microarray expression profile revealed that the mRNA level of IRAK1 gene was down-regulated by miR-146b. The 3' UTR of IRAK1 mRNA was found to be a molecular target of miR-146b posttranscriptional repression in BCPAP cells by reporter gene assays. MiR-146b promoted the migration and proliferation of PTC cells by down-regulating IRAK1 expression, whereas restoration of IRAK1 expression reversed this effect. In addition, the expression of IRAK1 mRNA was significantly lower in PTC clinical tissue samples than normal adjacent thyroid specimens and showed a strong inverse correlation with the expression of miR-146b in PTC specimens. CONCLUSION: Our results demonstrated that IRAK1 is a direct target of miR-146b and has functional roles to inhibit various aggressive PTC cell activities. In conjunction with current therapeutic regimens, targeting the miR-146b-IRAK1 axis may provide a potential approach for PTC management.
引用
- Chou CK, Chi SY, Huang CH, et al. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016. PMID: 27533309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。